APO RESEARCH · REPORT
Extracorporeal Membrane Oxygenation (ECMO) Systems
Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
Product & engineering
Understand the product.
Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
Selected research
Market Structure
Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
The global extracorporeal membrane oxygenation (ECMO) system market is dominated by North America (41%) and Europe (34%). The market is growing due to improved patient safety and awareness among the doctors and patients. The Asian market is growing due to increasing adoption rate of ECMO machine in hospitals, success rate of ECMO & government initiatives, and growing awareness towards ECMO.
This market is segmented and forecast on the basis of modality, application and geography. The modality comprises of Veno Artrial (VA), Veno Venous (VV), the Veno Venous (VV) contributed to 61.82% of global market of ECMO system industry.
Read the full market overview
For China market, the industry is developing rapidly. The main players are Medtronic, Maquet, Sorin, Terumo and Xenios. Medtronic and Maquet enjoy more than 50% market share.
This report provides an overview of the global Extracorporeal Membrane Oxygenation (ECMO) Systems market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Extracorporeal Membrane Oxygenation (ECMO) Systems and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Extracorporeal Membrane Oxygenation (ECMO) Systems sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Extracorporeal Membrane Oxygenation (ECMO) Systems market size, projected growth trends, production technologies, key applications, and end-use industries.
Extracorporeal Membrane Oxygenation (ECMO) Systems Segment by Company
Medtronic
Maquet
Sorin
Terumo
Xenios
Extracorporeal Membrane Oxygenation (ECMO) Systems Segment by Type
VA (Veno-Arterial) ECMO
VV (Veno-Venous) ECMO
Extracorporeal Membrane Oxygenation (ECMO) Systems Segment by Application
Neonatal
Pediatric
Adult
Extracorporeal Membrane Oxygenation (ECMO) Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Extracorporeal Membrane Oxygenation (ECMO) Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Extracorporeal Membrane Oxygenation (ECMO) Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Extracorporeal Membrane Oxygenation (ECMO) Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Extracorporeal Membrane Oxygenation (ECMO) Systems market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Extracorporeal Membrane Oxygenation (ECMO) Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Extracorporeal Membrane Oxygenation (ECMO) Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Extracorporeal Membrane Oxygenation (ECMO) Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- VA (Veno-Arterial) ECMO
- VV (Veno-Venous) ECMO
Applications
- Neonatal
- Pediatric
- Adult
Companies covered
- Medtronic
- Maquet
- Sorin
- Terumo
- Xenios
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Dynamics
- 2.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Trends
- 2.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Drivers
- 2.3 Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Opportunities and Challenges
- 2.4 Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Restraints
3 Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Manufacturers
- 3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Manufacturers (2021-2026)
- 3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Manufacturers (2021-2026)
- 3.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Manufacturers, Product Type & Application
- 3.7 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Extracorporeal Membrane Oxygenation (ECMO) Systems Players Market Share by Revenue in 2025
- 3.8.3 2025 Extracorporeal Membrane Oxygenation (ECMO) Systems Tier 1, Tier 2, and Tier 3
4 Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Type
- 4.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Type Introduction
- 4.1.1 VA (Veno-Arterial) ECMO
- 4.1.2 VV (Veno-Venous) ECMO
- 4.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Type
- 4.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Type (2021-2032)
- 4.2.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Type (2021-2032)
- 4.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Type
- 4.3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Type (2021-2032)
- 4.3.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Type (2021-2032)
5 Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Application
- 5.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Application Introduction
- 5.1.1 Neonatal
- 5.1.2 Pediatric
- 5.1.3 Adult
- 5.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Application
- 5.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Application (2021-2032)
- 5.2.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Application (2021-2032)
- 5.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Application
- 5.3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Application (2021-2032)
- 5.3.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Application (2021-2032)
6 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region
- 6.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region (2021-2032)
- 6.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region (2021-2026)
- 6.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region
- 7.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region
- 7.1.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region (2021-2026)
- 7.1.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region (2027-2032)
- 7.1.4 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (2021-2032)
- 7.2.2 North America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (2021-2032)
- 7.3.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (2021-2032)
- 7.4.2 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Medtronic
- 8.1.1 Medtronic Company Information
- 8.1.2 Medtronic Business Overview
- 8.1.3 Medtronic Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Medtronic Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
- 8.1.5 Medtronic Recent Developments
- 8.2 Maquet
- 8.2.1 Maquet Company Information
- 8.2.2 Maquet Business Overview
- 8.2.3 Maquet Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Maquet Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
- 8.2.5 Maquet Recent Developments
- 8.3 Sorin
- 8.3.1 Sorin Company Information
- 8.3.2 Sorin Business Overview
- 8.3.3 Sorin Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sorin Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
- 8.3.5 Sorin Recent Developments
- 8.4 Terumo
- 8.4.1 Terumo Company Information
- 8.4.2 Terumo Business Overview
- 8.4.3 Terumo Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Terumo Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
- 8.4.5 Terumo Recent Developments
- 8.5 Xenios
- 8.5.1 Xenios Company Information
- 8.5.2 Xenios Business Overview
- 8.5.3 Xenios Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Xenios Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
- 8.5.5 Xenios Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Value Chain Analysis
- 9.1.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Extracorporeal Membrane Oxygenation (ECMO) Systems Production Mode & Process
- 9.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Distributors
- 9.2.3 Extracorporeal Membrane Oxygenation (ECMO) Systems Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst